Stephens Inc Pfizer Inc Transaction History

Stephens Inc

$6.31 Billion
Q2 2024

A detailed history of Stephens Inc transactions in Pfizer Inc stock. As of the latest transaction made, Stephens Inc holds 379,237 shares of PFE stock, worth $11 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

379,237

Previous 421,781 10.09%

Holding current value

$11 Million

Previous $11.7 Million 9.34%

% of portfolio

0.17%

Previous 0.19%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$25.26 - $29.6 $1.07 Million - $1.26 Million	-42,544 Reduced 10.09%	379,237 $10.6 Million
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $1.6 Million - $1.84 Million	-61,988 Reduced 12.81%	421,781 $11.7 Million
Q4 2023 Feb 13, 2024	SELL	$26.13 - $33.94 $339,637 - $441,152	-12,998 Reduced 2.62%	483,769 $13.9 Million
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $536,480 - $627,092	-16,718 Reduced 3.26%	496,767 $16.5 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $277,293 - $320,821	7,677 Added 1.52%	513,485 $18.8 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $1.81 Million - $2.35 Million	45,891 Added 9.98%	505,808 $20.6 Million
Q4 2022 Jan 25, 2023	SELL	$41.75 - $54.5 $1.37 Million - $1.79 Million	-32,897 Reduced 6.68%	459,917 $23.6 Million
Q3 2022 Nov 02, 2022	BUY	$43.76 - $53.42 $436,243 - $532,543	9,969 Added 2.06%	492,814 $21.6 Million
Q2 2022 Aug 03, 2022	BUY	$46.53 - $55.17 $288,113 - $341,612	6,192 Added 1.3%	482,845 $25.3 Million
Q1 2022 May 04, 2022	SELL	$45.75 - $56.69 $1.14 Million - $1.41 Million	-24,942 Reduced 4.97%	476,653 $24.7 Million
Q4 2021 Mar 07, 2022	SELL	$41.32 - $61.25 $21,816 - $32,340	-528 Reduced 0.11%	501,595 $29.6 Million
Q3 2021 Oct 27, 2021	SELL	$39.25 - $50.42 $2.54 Million - $3.26 Million	-64,671 Reduced 11.41%	502,123 $21.6 Million
Q2 2021 Aug 12, 2021	SELL	$35.91 - $40.68 $449,090 - $508,744	-12,506 Reduced 2.16%	566,794 $22.2 Million
Q1 2021 May 14, 2021	BUY	$33.49 - $37.77 $582,625 - $657,084	17,397 Added 3.1%	579,300 $21 Million
Q4 2020 Feb 10, 2021	BUY	$33.47 - $42.56 $204,602 - $260,169	6,113 Added 1.1%	561,903 $20.7 Million
Q3 2020 Nov 13, 2020	SELL	$31.75 - $37.25 $123,253 - $144,604	-3,882 Reduced 0.69%	555,790 $20.4 Million
Q2 2020 Aug 24, 2020	SELL	$30.12 - $36.54 $667,790 - $810,128	-22,171 Reduced 3.81%	559,672 $18.3 Million
Q1 2020 May 14, 2020	SELL	$27.03 - $38.62 $33,030 - $47,193	-1,222 Reduced 0.21%	581,843 $19 Million
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $1.66 Million - $1.88 Million	50,349 Added 9.45%	583,065 $22.8 Million
Q3 2019 Oct 18, 2019	BUY	$32.49 - $42.13 $2.37 Million - $3.07 Million	72,894 Added 15.85%	532,716 $19.1 Million
Q2 2019 Aug 01, 2019	BUY	$36.98 - $41.52 $1.64 Million - $1.84 Million	44,288 Added 10.66%	459,822 $19.9 Million
Q1 2019 May 03, 2019	BUY	$37.5 - $41.2 $367,050 - $403,265	9,788 Added 2.41%	415,534 $17.6 Million
Q4 2018 Feb 11, 2019	SELL	$38.47 - $43.86 $2.75 Million - $3.14 Million	-71,567 Reduced 14.99%	405,746 $17.7 Million
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $553,760 - $671,677	16,065 Added 3.48%	477,313 $21 Million
Q2 2018 Aug 10, 2018	BUY	$32.98 - $35.16 $1.29 Million - $1.38 Million	39,202 Added 9.29%	461,248 $16.7 Million
Q1 2018 May 03, 2018	BUY	$31.91 - $37.02 $641,710 - $744,472	20,110 Added 5.0%	422,046 $15 Million
Q4 2017 Feb 05, 2018	SELL	$33.26 - $35.29 $94,524 - $100,294	-2,842 Reduced 0.7%	401,936 $14.6 Million
Q3 2017 Nov 08, 2017	BUY	$31.0 - $34.15 $11,656 - $12,840	376 Added 0.09%	404,778 $14.5 Million
Q2 2017 Aug 10, 2017	BUY	N/A	404,402	404,402 $13.6 Million

Others Institutions Holding PFE

# of Institutions

3,220

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $163B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stephens Inc , based on Form 13F filings with the SEC.

News

Stay updated on Stephens Inc with notifications on news.

Account